Hap Trading, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Hap Trading, LLC

  • $872 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 11, 2020
BUY
$40.86 - $57.65 $3.02 Million - $4.26 Million
73,953 Added 415.49%
91,752 $5 Million
Q3 2019

Nov 12, 2019
BUY
$37.38 - $49.47 $665,326 - $880,516
17,799 New
17,799 $743,000
Q2 2018

Aug 13, 2018
SELL
$23.62 - $42.29 $475,872 - $852,016
-20,147 Closed
0 $0
Q1 2018

May 11, 2018
BUY
$22.49 - $34.56 $453,106 - $696,280
20,147 New
20,147 $519,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email